ALZN: Alzamend Neuro Cash per Share

Alzamend Neuro, Inc. (ALZN) protects its margins from logistical disruptions through the diversification of its research centers. The trend of highly liquid assets per share on the GURU.Markets terminal linear chart contains the 1.58 indicator, which captures the current state of the parameter. Pricing power potential is based on lithium delivery patents, although the venture nature of early-stage developments renders future returns speculative.
Comprehensive metric breakdowns and analytics for Alzamend Neuro (ALZN)

For Alzamend Neuro, Inc. (ALZN), this indicator serves as a measure of financial stability amidst venture risks. The metric is calculated as the ratio of the net cash position to the number of shares outstanding. By analyzing this cash per share chart, an investor determines the actual value of the liquid collateral for each share. For a company with early-stage patents, this reserve is critical when funding clinical trials. A sufficient volume of funds mitigates competitive pressure from pharma behemoths.